INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

19小时前 neuro_2008 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：今年影响因子能过5吗

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-05-10 爱科研的小申来自江苏省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：meta分析;肿瘤免疫
经验分享：Jan 17, 2024, Submitted to Journal
Feb 06, 2024, With Editor
Feb 07, 2024, Under Review
Mar 23, 2024, Required Reviews Completed
Mar 25, 2024, Review Completed
Apr 5, 2024, Major Revision
Apr 7, 2024, With Editor
May 2, 2024, Under Review
May 4, 2024, Required Reviews Completed
May 8, 2024, Accept

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-04-30 ms9000000167770666 来自新疆

2024-03-26投稿
03-26 with editor
03-26 under review
03-28 under review 有一个审稿人接受审稿
04-15 under review 有一个审稿人完成审稿
编辑没有再邀请审稿人，是否能催一下？

7 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-05-03 148817e2m02暂无昵称来自江苏省

20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2023-09-27 ms8000001070008739 来自上海

9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……

20 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-04-12 ms5000001369677749 来自江苏省

一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的

16 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-04-04 WWW9450 来自山东省

现在稿号到多少了

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-01-09 洛洛仔111 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：免疫学;生信
经验分享：投了五天了还是submit状态，后续更新进度

82 34

展开34条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-04-24 ms2000002142798745 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：免疫;肿瘤
经验分享：12.25投稿
2.27大修
3.17修回
4.18RRC到现在，是不是希望不大了，能写信催一下吗？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2204789, encodeId=2b252204e89af, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：今年影响因子能过5吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e80a1446568, createdName=neuro_2008, createdTime=Wed May 15 11:11:20 CST 2024, time=19小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203904, encodeId=8da32203904dc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;肿瘤免疫 经验分享：Jan 17, 2024, Submitted to Journal Feb 06, 2024, With Editor Feb 07, 2024, Under Review Mar 23, 2024, Required Reviews Completed Mar 25, 2024, Review Completed Apr 5, 2024, Major Revision Apr 7, 2024, With Editor May 2, 2024, Under Review May 4, 2024, Required Reviews Completed May 8, 2024, Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=12086428503, createdName=爱科研的小申, createdTime=Fri May 10 15:04:21 CST 2024, time=2024-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2201639, encodeId=7a9b220163910, content=20240218投稿在20240420左右催稿到现在都没回复我催稿信看状态是有2个评审人接受了审稿，但是只有一个回稿了这个杂志是不是要求至少3个审稿人哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Fri May 03 17:15:50 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：12.25投稿 2.27大修 3.17修回 4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症 经验分享：记录状态： 2024.03.15提交手稿 2024.03.18With Editor 发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省)]

2024-03-28 ms1000001286002339 来自四川省

偏重的研究方向：免疫;炎症
经验分享：记录状态：
2024.03.15提交手稿
2024.03.18With Editor
发过一封催稿邮件没有回复

8 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务